Hans Klingemann

Hans Klingemann

Company: ImmunityBio

Job title: CSO


Allogeneic NK-92 Cells: Advancing from Pre-Clinical Development to Clinical Application 10:00 am

Recapping the pre-clinical development of NK-92 and its clonal ‘offsprings’ Showcasing the outcome of first clinical studies Reviewing novel NK-92 based variants expressing FcR, CARs and immune modulatorsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.